RESUMEN
AIMS: Although reduced life expectancy in Parkinson's Disease (PD) patients has been related to severe cardiac arrhythmias due to autonomic dysfunctions, its molecular mechanisms remain unclear. To investigate the role of cardiac ß1-Adrenergic (ß1AR) and A1-Adenosine (A1R) receptors in these dysfunctions, the pharmacological effects of stimulation of cardiac ß1AR (isoproterenol, ISO), in the absence and presence of cardiac ß1AR (atenolol, AT) or A1R (1,3-dipropyl-8-cyclopentyl xanthine, DPCPX) blockade, on the arrhythmias induced by Ischemia/Reperfusion (CIR) in an animal PD model were studied. METHODS: PD was produced by dopaminergic lesions (confirmed by immunohistochemistry analysis) caused by the injection of 6-hydroxydopamine (6-OHDA, 6 µg) in rat striatum. CIR was produced by a surgical interruption for 10 min followed by reestablishment of blood circulation in the descendent left coronary artery. On the incidence of CIR-Induced Ventricular Arrhythmias (VA), Atrioventricular Block (AVB), and Lethality (LET), evaluated by Electrocardiogram (ECG) analysis, the effects of intravenous treatment with ISO, AT and DPCPX (before CIR) were studied. RESULTS: VA, AVB and LET incidences were significantly higher in 6-OHDA (83%, 92%, 100%, respectively) than in control rats (58%, 67% and 67%, respectively). ISO treatment significantly reduced these incidences in 6-OHDA (33%, 33% and 42%, respectively) and control rats (25%, 25%, 33%, respectively), indicating that stimulation of cardiac ß1AR induced cardioprotection. This response was prevented by pretreatment with AT and DPCPX, confirming the involvement of cardiac ß1AR and A1R. CONCLUSION: Pharmacological modulation of cardiac ß1AR and A1R could be a potential therapeutic strategy to reduce severe arrhythmias and increase life expectancy in PD patients.
Asunto(s)
Adrenérgicos , Enfermedad de Parkinson , Ratas , Animales , Adrenérgicos/uso terapéutico , Oxidopamina/uso terapéutico , Arritmias Cardíacas/etiología , Receptores Purinérgicos P1/uso terapéuticoRESUMEN
Abstract Aims Although reduced life expectancy in Parkinson's Disease (PD) patients has been related to severe cardiac arrhythmias due to autonomic dysfunctions, its molecular mechanisms remain unclear. To investigate the role of cardiac β1-Adrenergic (β1AR) and A1-Adenosine (A1R) receptors in these dysfunctions, the pharmacological effects of stimulation of cardiac β1AR (isoproterenol, ISO), in the absence and presence of cardiac β1AR (atenolol, AT) or A1R (1,3-dipropyl-8-cyclopentyl xanthine, DPCPX) blockade, on the arrhythmias induced by Ischemia/Reperfusion (CIR) in an animal PD model were studied. Methods PD was produced by dopaminergic lesions (confirmed by immunohistochemistry analysis) caused by the injection of 6-hydroxydopamine (6-OHDA, 6 μg) in rat striatum. CIR was produced by a surgical interruption for 10 min followed by reestablishment of blood circulation in the descendent left coronary artery. On the incidence of CIR-Induced Ventricular Arrhythmias (VA), Atrioventricular Block (AVB), and Lethality (LET), evaluated by Electrocardiogram (ECG) analysis, the effects of intravenous treatment with ISO, AT and DPCPX (before CIR) were studied. Results VA, AVB and LET incidences were significantly higher in 6-OHDA (83%, 92%, 100%, respectively) than in control rats (58%, 67% and 67%, respectively). ISO treatment significantly reduced these incidences in 6-OHDA (33%, 33% and 42%, respectively) and control rats (25%, 25%, 33%, respectively), indicating that stimulation of cardiac β1AR induced cardioprotection. This response was prevented by pretreatment with AT and DPCPX, confirming the involvement of cardiac β1AR and A1R. Conclusion Pharmacological modulation of cardiac β1AR and A1R could be a potential therapeutic strategy to reduce severe arrhythmias and increase life expectancy in PD patients.
RESUMEN
BACKGROUND: Cardiovascular dysfunctions are common non-motor symptoms in patients with Parkinson's disease (PD) that can result in reduced quality of life and even death. Research in animal models designed to characterize the pathological association between PD and cardiovascular abnormalities is still in its infancy. This study assessed the early impact of the nigrostriatal dopaminergic damage on cardiological features in the unilateral 6-OHDA rat model of PD. METHODS: Male Wistar rats received unilateral intrastriatal injections of 6-OHDA and sham rats were injected with saline. Animals were studied 15 days later. Immunohistochemistry was used for visualization of tyrosine hydroxylase (TH)-positive neurons in the nigrostriatal system. Electrocardiogram recordings of heart rate were performed in conscious rats. Heart levels of vitamin D, inflammatory cytokines and C-reactive protein were assessed through electrochemiluminescence immunoassay, quantitative reverse transcription PCR and turbidimetric method, respectively. RESULTS: We found a post-injury reduction of TH-immunoreactivity of approximately 45% in the substantia nigra pars compacta and 20% in the striatum. Heart rate reduction was found in 6-OHDA-lesioned rats as compared with sham counterparts. Reduced levels of vitamin D and increased levels of inflammatory factors (C-reactive protein, IL-6, TNF-α and TGF-ß) were detected in the heart tissue of PD rats in comparison with sham. CONCLUSION: Our findings suggest a link between cardiac tissue changes and cardiac functional changes early after the central dopaminergic damage induced by 6-OHDA. Knowledge of the cardiac abnormalities in the 6-OHDA model is critical in identifying future therapeutic targets and disease-modifying approaches for PD non-motor features.
Asunto(s)
Proteína C-Reactiva/análisis , Citocinas/sangre , Miocardio/metabolismo , Enfermedad de Parkinson/metabolismo , Vitamina D/sangre , Animales , Biomarcadores/sangre , Cuerpo Estriado/efectos de los fármacos , Cuerpo Estriado/metabolismo , Cuerpo Estriado/patología , Modelos Animales de Enfermedad , Neuronas Dopaminérgicas/efectos de los fármacos , Neuronas Dopaminérgicas/metabolismo , Neuronas Dopaminérgicas/patología , Electrocardiografía , Frecuencia Cardíaca/efectos de los fármacos , Masculino , Oxidopamina/administración & dosificación , Enfermedad de Parkinson/sangre , Enfermedad de Parkinson/inmunología , Ratas WistarAsunto(s)
Canales de Calcio/metabolismo , Calcio/metabolismo , Cardiopatías/tratamiento farmacológico , Enfermedad de Parkinson/metabolismo , Canales de Calcio/uso terapéutico , Cardiopatías/etiología , Homeostasis/fisiología , Humanos , Enfermedad de Parkinson/complicaciones , Enfermedad de Parkinson/patologíaAsunto(s)
Humanos , Enfermedad de Parkinson/metabolismo , Canales de Calcio/metabolismo , Calcio/metabolismo , Cardiopatías/tratamiento farmacológico , Enfermedad de Parkinson/complicaciones , Enfermedad de Parkinson/patología , Canales de Calcio/uso terapéutico , Cardiopatías/etiología , Homeostasis/fisiologíaAsunto(s)
Prevención de Enfermedades , Estrés Oxidativo , Radicales Libres/metabolismo , Radicales Libres/toxicidad , Ingesta Diaria Recomendada/tendencias , Antioxidantes/farmacocinética , Antioxidantes/uso terapéutico , Oxidantes/antagonistas & inhibidores , Oxidantes/efectos adversos , Oxidantes/toxicidadRESUMEN
La terapia por quelacion consiste en el uso de aminoacidos no esenciales, para eliminar del organismo iones minerales, principalmente los denominados metales pesados; siendo un importante auxiliar terapeutico en el control de procesos isquemicos, enfermedades degenerativas cronicas, envejecimiento y el cancer. Se revisaron los conceptos cientificos que la consolidan, asi como se analizaron los estudios empiricos publicados, principalmente por parte del autor
Asunto(s)
Aminoácidos/uso terapéutico , Quelantes , Enfermedad Crónica/terapia , Iones/efectos adversos , Bolivia , Radicales LibresRESUMEN
Parece existir uma relaçäo causal entre radicais livres e isquemia por reperfusäo tissular, referente ao processo hipóxia-reoxigenbaçäo. É apresentada uma revisäo da bioquímica dos radicais libres e dos estudos demonstrativos de que estas moléculas constituem fator causal da isquemia
Asunto(s)
Radicales Libres , Infarto del Miocardio/etiología , Daño por Reperfusión Miocárdica/inducido químicamenteRESUMEN
La participación de los Radicales libres (RL) en la génesis de los procesos isquémicos por reperfusión, ha adquirido amplia notoriedad en los últimos tiempos, habiendo, las recientes investigaciones, demostrado que, la reoxigenación del miocardio en hipoxia, determina un aumento de tejido lesionado. Existen evidencias que sugieren la participación de los RL, en forma total o parcial, en la producción de lesión microvascular de las células parenquimatosas en los tejidos isquemiados, a través del proceso hipoxia reoxiganación